Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $2.56 Million - $3.01 Million
50,000 Added 59.74%
133,700 $7.06 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $18.8 Million - $29.4 Million
-392,200 Reduced 82.41%
83,700 $4.53 Million
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $55.8 Million - $94.7 Million
-876,000 Reduced 64.8%
475,900 $33.4 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $36.3 Million - $113 Million
1,348,600 Added 40866.67%
1,351,900 $113 Million
Q3 2023

Nov 14, 2023

BUY
$29.46 - $36.61 $97,218 - $120,813
3,300 New
3,300 $97,000
Q2 2022

Aug 15, 2022

BUY
$33.93 - $48.92 $1.02 Million - $1.47 Million
30,000 Added 100.0%
60,000 $2.36 Million
Q4 2021

Feb 11, 2022

SELL
$34.35 - $46.38 $2.92 Million - $3.94 Million
-85,000 Reduced 73.91%
30,000 $1.37 Million
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $1.28 Million - $2.47 Million
69,000 Added 150.0%
115,000 $4.11 Million
Q2 2021

Aug 16, 2021

BUY
$19.79 - $26.99 $910,340 - $1.24 Million
46,000 New
46,000 $911,000
Q1 2021

May 17, 2021

SELL
$18.57 - $25.68 $603,525 - $834,600
-32,500 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$15.26 - $28.61 $6.24 Million - $11.7 Million
-409,000 Reduced 92.64%
32,500 $675,000
Q3 2020

Nov 16, 2020

BUY
$20.58 - $28.96 $9.01 Million - $12.7 Million
437,800 Added 11832.43%
441,500 $9.56 Million
Q2 2020

Aug 14, 2020

BUY
$11.15 - $24.64 $41,255 - $91,168
3,700 New
3,700 $88,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.15B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.